029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
MPR483f前列腺癌及前列腺组织组合芯片,附病理分级、TNM、临床分期,替代MPR483e
点 数48例 数48
行 数6列 数8
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:MPR483f
 
前列腺癌及胰腺组织组合微阵列芯片,包含腺癌40例,前列腺组织8例,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Pro
-Prostate
 
Malignant (I)
 
Malignant (II)
 
Malignant (III)
 
Malignant (IV)
 
Normal (*)
TISSUE  ARRAYS MPR483f
1
2
3
4
5
6
7
8
A
PRO
PRO
PRO
PRO
PRO
PRO
PRO
PRO
B
PRO
PRO
PRO
PRO
PRO
PRO
PRO
PRO
C
PRO
PRO
PRO
PRO
PRO
PRO
PRO
PRO
D
PRO
PRO
PRO
PRO
PRO
PRO
PRO
PRO
E
PRO
PRO
PRO
PRO
PRO
PRO
PRO
PRO
F
PRO
PRO
PRO
PRO
PRO
PRO
PRO
PRO
Tis
MPR483f(A1)
Age:70
Sex:M
Organ(Anatomic Site):Prostate
Pathology diagnosis:Adenocarcinoma (Gleason Grade:1 ;Gleason Score3+3)
Grade:*
TNM:T3N0M0
Stage:III
Tissue ID:Mpr060100
Type:Malignant
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1170MProstateAdenocarcinoma (Gleason Grade:1 ;Gleason Score3+3)*T3N0M0IIIMalignantN
A2273MProstateAdenocarcinoma (Gleason Grade:1 ;Gleason Score3+3)*T3N0M0IIIMalignantN
A3368MProstateAdenocarcinoma (Gleason Grade:1 ;Gleason Score3+3)(sparse)*T2bN0M0IIMalignantN
A4468MProstateAdenocarcinoma (Gleason Grade:2 ;Gleason Score3+4)(sparse)*T1N0M0IMalignantN
A5573MProstateAdenocarcinoma (Gleason Grade:2 ;Gleason Score3+4)*T3N0M0IIIMalignantN
A6664MProstateAdenocarcinoma (Gleason Grade:2 ;Gleason Score3+4)*T2N0M0IIMalignantN
A7775MProstateAdenocarcinoma (Gleason Grade:2 ;Gleason Score3+4) (sparse)*T2N0M0IIMalignantN
A8857MProstateAdenocarcinoma (Gleason Grade:2 ;Gleason Score3+4)*T2aN0M0IMalignantN
B1971MProstateAdenocarcinoma (Gleason Grade:2 ;Gleason Score3+4)*T2N0M0IIMalignantN
B21066MProstateAdenocarcinoma (Gleason Grade:2 ;Gleason Score3+4)*T2N0M0IIMalignantN
B31164MProstateAdenocarcinoma (Gleason Grade:2 ;Gleason Score3+4)*T2N0M0IIMalignantN
B41260MProstateAdenocarcinoma (Gleason Grade:2 ;Gleason Score3+4)*T3N1M0IVMalignantN
B51364MProstateAdenocarcinoma (Gleason Grade:3 ;Gleason Score4+3)*T3N0M0IIIMalignantN
B61473MProstateAdenocarcinoma (Gleason Grade:3 ;Gleason Score4+3)*T2aN0M0IMalignantN
B71575MProstateAdenocarcinoma (Gleason Grade:3 ;Gleason Score4+3)*T3N0M0IIIMalignantN
B81669MProstateAdenocarcinoma (Gleason Grade:4 ;Gleason Score3+5)*T2N0M0IIMalignantN
C11762MProstateAdenocarcinoma with necrosis (Gleason Grade:4 ;Gleason Score4+4)*T2N0M0IIMalignantN
C21870MProstateAdenocarcinoma (Gleason Grade:4 ;Gleason Score4+4)*T2N0M0IIMalignantN
C31920MProstateAdenocarcinoma (Gleason Grade:4 ;Gleason Score4+4)*T3N0M0IIIMalignantN
C42066MProstateAdenocarcinoma (Gleason Grade:4 ;Gleason Score4+4)(sparse)*T3N1M1cIVMalignantN
C52161MProstateAdenocarcinoma (Gleason Grade:4 ;Gleason Score4+4)*T3N0M0IIIMalignantN
C62262MProstateAdenocarcinoma (Gleason Grade:4 ;Gleason Score4+4)*T2N0M0IIMalignantN
C72369MProstateAdenocarcinoma with necrosis (Gleason Grade:4 ;Gleason Score4+4)*T3N0M0IIIMalignantN
C82472MProstateAdenocarcinoma (Gleason Grade:4 ;Gleason Score4+4)*T3N0M0IIIMalignantN
D12571MProstateAdenocarcinoma (Gleason Grade:4 ;Gleason Score5+3)*T2N0M0IIMalignantN
D22664MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score4+5)*T2N0M0IIMalignantN
D32772MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score4+5)*T3N0M0IIIMalignantN
D42874MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score4+5)*T2N0M0IIMalignantN
D52972MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score4+5)*T2N0M0IIMalignantN
D63066MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score4+5)*T3aN0M0IIIMalignantN
D73181MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score4+5)*T3aN0M0IIIMalignantN
D83276MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score5+4)*T3bN0M0IIIMalignantN
E13365MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score5+4)*T2N0M0IIMalignantN
E23470MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score5+4)*T2N0M0IIMalignantN
E33560MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score5+4)*T3aN0M0IIIMalignantN
E43665MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score5+4)*T2N0M0IIMalignantN
E53764MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score5+4)*T3N0M0IIIMalignantN
E63880MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score5+4)*T3N0M0IIIMalignantN
E73956MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score5+4)*T3N0M0IIIMalignantN
E84034MProstateAdenocarcinoma (Gleason Grade:5 ;Gleason Score5+5)*T2bN0M0IIMalignantN
F14131MProstateProstate tissue***NormalN
F24245MProstateProstate tissue***NormalN
F34330MProstateProstate tissue***NormalN
F44431MProstateProstate tissue***NormalN
F54535MProstateProstate tissue***NormalN
F64650MProstateProstate tissue***NormalN
F74730MProstateProstate tissue (sparse)***NormalN
F84855MProstateProstate tissue***NormalN
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情